Gene expression of TNF-receptors in peripheral blood mononuclear cells of patients with alcoholic cirrhosis

Journal of Hepatology

Volumn 32, Issue 1, 2000, Pages 51-57

  Hanck, Christoph ^a,b   Glatzel, Michael ^a   Singer, Manfred Vincenz ^a   Rossol, Siegbert ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Christoph Hanck   (Germany)

Author keywords

Alcoholic cirrhosis; Cytokine gene expression; Soluble tumor necrosis factor receptors; Tumor necrosis factor ; Unstimulated peripheral blood mononuclear cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALCOHOL; AMMONIA; BILIRUBIN; CHOLINESTERASE; INTERLEUKIN 10; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033958145     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80189-0     Document Type: Article

References (50)

1. Van der Poll T, Calvano SE, Kumar A, Braxton CC, Coyle SM, Barbosa K, et al. Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans. Blood. 86:1995;2754-2759.
2. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 103:1992;264-274.
3. Le J, Vilcek J. Biology of disease. Tumour necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest. 56:1987;234-248.
4. McCuskey RS, Nishida J, Eguchi H, McDonnel D, Baker GL, Ekataksin W, et al. Role of endotoxin in the hepatic microvascular inflammatory response to ethanol. J Gastroenterol Hepatol. 10:1995;S18-S23.
5. Schulze-Osthoff K, Beyaert R, Vandervoorde V, Haegeman G, Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-induced effects of TNF. EMBO J. 12:1993;3095-3104.
6. Naveau S, Emilie D, Balian A, Grangeot-Keros L, Borotto E, Portier A, et al. Plasma levels of soluble tumor necrosis factor receptor p55 and p75 in patients with alcoholic liver disease of increasing severity. J Hepatol. 28:1998;778-784.
7. Diez Ruiz A, Santos Perez JL, Lopez Martinez G, Gonzalez Calvin J, Gil Extremera B, Gutierrez Gea F. Tumour necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis. Alcohol Alcohol. 28:1993;319-323.
8. Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, et al. Circulating interleukin 1 and tumor necrosis factor antagonists in liver disease. Hepatology. 18:1993;1132-1138.
9. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H. Neopterin and soluble tumor necrosis factor receptor type I in alcoholic cirrhosis. Hepatology. 21:1995;976-978.
10. Hanck C, Rossol S, Boecker U, Tokus M, Singer MV. Presence of plasma endotoxin is correlated with TNF receptor levels and disease activity in alcoholic cirrhosis. Alcohol Alcohol. 33:1998;606-608.
11. McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis. 13:1993;170-182.
12. Decker T, Lohmann-Matthes ML, Karck U, Peters T, Decker K. Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages. J Leukoc Biol. 45:1989;139-146.
13. Schäfer C, Schips I, Landig J, Bode JC, Bode C. Tumor-necrosisfactor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease. Z Gastroenterol. 33:1995;503-508.
14. Manrekar P, Catalano D, Szabo G. Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. Alcohol Clin Exp Res. 21:1997;988-994.
15. Laso FJ, Lapena P, Madruga JI, San Miguel JF, Orfao A, Iglesias MC, et al. Alterations in tumor necrosis factor-alpha, interferon gamma and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake. Alcohol Clin Exp Res. 21:1997;1226-1231.
16. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 147:1991;3815-3822.
17. Hibbs JBJ, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 138:1987;550-565.
18. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol. 24:1994;1941-1944.
19. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-648.
20. Luna-Casado L, Diez-Ruiz A, Gutierrez-Gea F, Santos-Perez JL, Rico-Irles J, Wachter H, et al. Increased peripheral mononuclear cells expression of adhesion molecules in alcoholic cirrhosis: its relation to immune activation. J Hepatol. 27:1997;477-483.
21. Devière J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology. 11:1990;628-634.
22. Devière J, Vaerman JP, Content J, Denys C, Schandene L, Vandenbussche P, et al. IgA triggers tumor necrosis factor alpha secretion by monocytes: a study in normal subjects and patients with alcoholic cirrhosis. Hepatology. 13:1991;670-675.
23. Maadrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 75:1978;193-199.
24. Pasqualetti P, Festuccia V, Maccarone C, Di Lauro G, Casale R. Valore diagnostico della gamma-glutamiltranspeptidasi e del volume corpusculare medio per l'etiologia alcolica in corso di epatopatia cronica. Minerva Med. 1995:1995;395-402.
25. Watson RR, Mohs ME, Eskelson C, Sampliner RE. Identification of alcohol abuse and alcoholism with biological parameters. Alcoholism. 10:1986;364-385.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium Thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-163.
27. Ditter B, Becker KP, Urbaschek R, Urbaschek B. Quantitative determination of endotoxin; automated limulus amoebocyte lysate microtiter U test with determination of sample-related interference. Drug Red. 33:1983;681-687.
28. Grell M, Zimmermann G, Hulser D, Pfizenmaier K, Scheurich P. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol. 153:1994;1963-1972.
29. Schraut W, Wendelgass P, Calzada-Wack JC, Frankenberger M, Loems Ziegler-Heitbrock HW. TNF gene expression in monocytes of low and high responder individuals. Cytokine. 3:1997;206-211.
30. Kornbluth RS, Gregory SA, Edgington TS. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-α release from human peripheral blood mononuclear cells. J Immunol. 141:1988;2006-2015.
31. Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumour necrosis factor a production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology. 10:1989;769-773.
32. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 13:1991;267-276.
33. Fukui H, Brauner H, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol. 12:1991;162-169.
34. Schaefer C, Greiner B, Landig J, Feil E, Schuetz ET, Bode JC, et al. Decreased endotoxin binding capacity of whole blood in patients with alcoholic liver disease. J Hepatol. 26:1997;567-573.
35. Schaefer C, Schips I, Landig J, Bode JC, Bode C. Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease. Z Gastroenterol. 33:1995;503-508.
36. Batey R, Cao Q, Madsen G, Pang G, Russell A, Clancy R. Decreased tumor necrosis factor-alpha and interleukin-1alpha production from intrahepatic mononuclear cells in chronic ethanol consumption and upregulation by endotoxin. Alcohol Clin Exp Res. 22:1998;150-156.
37. Thiemermann C, Ruetten H, Wu CC, Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthetase. Br J Pharmacol. 116:1995;2845-2851.
38. Marinos G, Naoumov NV, Rossol S, Torre F, Wong PYN, Gallati H, et al. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology. 108:1995;1453-1463.
39. Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, et al. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol. 32:1997;942-946.
40. Enomoto N, Ikejima K, Bradford B, Rivera C, Kono H, Brenner DA, et al. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology. 115:1998;443-451.
41. Kallinowski B, Haseroth K, Marinos G, Hanck C, Stremmel W, Theilmann L, et al. Induction of tumour necrosis factor (TNF) receptor type p 5 and p75 in patients with chronic hepatitis C virus (HV) infection. Clin Exp Immunol. 111:1998;269-277.
42. Verma BK, Fogarasi M, Szabo G. Down-regulation of tumor necrosis factor alpha activity by acute ethanol treatment in human peripheral blood monocytes. J Clin Immunol. 13:1993;8-22.
43. Santucci L, Fiorucci S, Chiorean M, Brunori PM, Di Matteo FM, Sidoni A, et al. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology. 111:1996;736-744.
44. Oswald IP, Wynn TA, Sher A, James S. Interleukin 10 inhibits macrophage microcidal activity by blocking the endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon γ-induced activation. Proc Natl Acad Sci USA. 89:1992;8676-8680.
45. DeWaal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL10 produced by monocytes. J Exp Med. 174:1991;1209-1220.
46. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Devière J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholic cirrhosis. Hepatology. 22:1995;1436-1439.
47. Daftarian PM, Kumar A, Kryworuchko M, Diaz-Mitoma F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. J Immunol. 157:1996;12-20.
48. Doughty LA, Patrene KD, Evans CH, Boggs SS, Robbins PD. Constitutive systemic expression of IL-1 Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10. Gene Ther. 4:1997;252-257.
49. Spitzer JJ, Bautista AP. Tolerance and sensitivity: ethanol and Kupffer cells. Gastroenterology. 115:1998;494-495.
50. Douni E, Kollias G. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin-α or the p55TNF-R. J Exp Med. 7:1998;1343-1352.